2,3-bis(3'-hydroxybenzyl)butyrolactone and Breast Carcinoma In Situ

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Breast Carcinoma In Situ in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang-Claude, J; Herpel, E; Jaskulski, S; Johnson, T; Jung, AY; Rudolph, A; Sinn, P; Thöne, K	1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Breast Carcinoma In Situ

Article	Year
Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients. Molecular nutrition & food research, 2017, Volume: 61, Issue:11 Topics: 4-Butyrolactone; Aged; Breast Carcinoma In Situ; Breast Neoplasms; Case-Control Studies; Cell Proliferation; Female; Genistein; Germany; Humans; Isoflavones; Ki-67 Antigen; Lignans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Phytoestrogens; Postmenopause; Prognosis; Receptor, ErbB-2; Tumor Burden	2017

Article

Year

Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.

Molecular nutrition & food research, 2017, Volume: 61, Issue:11

Topics: 4-Butyrolactone; Aged; Breast Carcinoma In Situ; Breast Neoplasms; Case-Control Studies; Cell Proliferation; Female; Genistein; Germany; Humans; Isoflavones; Ki-67 Antigen; Lignans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Phytoestrogens; Postmenopause; Prognosis; Receptor, ErbB-2; Tumor Burden

2017